Skip to main content

Animations

MJFF Publications

3211 - 3220 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: Mechanisms behind Neurological Conditions Revealed, Adjusted
    Journal Name: Genetic Engineering & Biotechnology News
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1089/gen.40.10.15
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Biomarker Use for Dementia With Lewy Body Diagnosis
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000414
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Well Water and Parkinson’s Disease in Medicare Beneficiaries: A Nationwide Case-Control Study
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-191793
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson’s Disease: A Feasibility Study
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-202188
    Citation Count: 31
  • Summary Details
    RESTRICTED
    Title: Tears – More to Them Than Meets the Eye: Why Tears Are A Good Source of Biomarkers in Parkinson'S Disease
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/bmm-2019-0364
    Citation Count: 19
  • Summary Details
    RESTRICTED
    Title: Effects of a community-based Exercise Program On mobility, balance, cognition, sleep, Activities of Daily living, and Quality of Life in PD: A Pilot Study
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/nmt-2019-0027
    Citation Count: 19
  • Summary Details
    OPEN
    Title: From Passive Patient to Engaged Partner: My Journey With Parkinson Disease
    Journal Name: Journal of Participatory Medicine
    Publisher: JMIR Publications Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2196/12566
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Application of the ‘5-2-1’ Screening Criteria in Advanced Parkinson’s Disease: Interim Analysis of DUOGLOBE
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/nmt-2020-0021
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2020.102944
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Alternative Splicing Regulation of an Alzheimer’s Risk Variant in CLU
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms21197079
    Citation Count: 16
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.